Encompass Health (NYSE:EHC) EVP Sells $71,309.92 in Stock

Encompass Health Corporation (NYSE:EHC) EVP Patrick William Tuer sold 682 shares of the business’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $104.56, for a total transaction of $71,309.92. Following the completion of the transaction, the executive vice president directly owned 24,755 shares of the company’s stock, valued at approximately $2,588,382.80. This represents a 2.68% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Encompass Health Trading Down 0.1%

Shares of NYSE EHC opened at $107.36 on Friday. Encompass Health Corporation has a 1-year low of $92.77 and a 1-year high of $127.99. The company has a market cap of $10.65 billion, a PE ratio of 17.92, a P/E/G ratio of 2.34 and a beta of 0.72. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.76. The company has a 50-day moving average of $102.99 and a two-hundred day moving average of $106.40.

Encompass Health (NYSE:EHC) last issued its quarterly earnings results on Thursday, April 30th. The company reported $1.60 EPS for the quarter, topping the consensus estimate of $1.51 by $0.09. Encompass Health had a net margin of 10.04% and a return on equity of 18.28%. The company had revenue of $1.59 billion during the quarter, compared to analysts’ expectations of $1.57 billion. During the same quarter in the previous year, the company earned $1.37 EPS. Encompass Health’s revenue was up 9.0% on a year-over-year basis. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. As a group, equities analysts expect that Encompass Health Corporation will post 5.97 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be issued a dividend of $0.19 per share. The ex-dividend date is Wednesday, July 1st. This represents a $0.76 dividend on an annualized basis and a yield of 0.7%. Encompass Health’s payout ratio is currently 12.69%.

Hedge Funds Weigh In On Encompass Health

Several large investors have recently modified their holdings of EHC. Royal Bank of Canada raised its position in shares of Encompass Health by 21.5% in the first quarter. Royal Bank of Canada now owns 88,470 shares of the company’s stock valued at $8,960,000 after purchasing an additional 15,677 shares during the period. Millennium Management LLC raised its position in shares of Encompass Health by 38.4% in the first quarter. Millennium Management LLC now owns 92,197 shares of the company’s stock valued at $9,338,000 after purchasing an additional 25,574 shares during the period. Caxton Associates LLP bought a new position in shares of Encompass Health in the first quarter valued at about $259,000. Walleye Capital LLC grew its stake in shares of Encompass Health by 667.6% in the second quarter. Walleye Capital LLC now owns 6,522 shares of the company’s stock valued at $800,000 after acquiring an additional 7,671 shares in the last quarter. Finally, Gamco Investors INC. ET AL acquired a new position in shares of Encompass Health in the second quarter valued at about $588,000. 97.25% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

EHC has been the subject of several research analyst reports. Wall Street Zen upgraded shares of Encompass Health from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. Barclays reduced their price target on shares of Encompass Health from $153.00 to $140.00 and set an “overweight” rating for the company in a report on Tuesday, May 5th. Two equities research analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Buy” and an average price target of $144.17.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.